Internal Medicine · Springfield, IL
NPI
1669604468
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
701 N 1st St
Springfield, IL, 62781
Phone (217) 545-0182
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
433 services
Medicare patients, 2024
27
Average age 58
Drug cost, 2024
$1.3M
10,006 prescriptions
Company payments, 2025
$2,289
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kwesi Grant-Acquah was code 99213 (office e&m - established), 171 times for 25 patients. In total Kwesi Grant-Acquah billed 433 services in 14 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 171 | 25 | $58.79 | $10K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 100 | 19 | $46.46 | $4,646 |
| 99214 Office E&M - Established | Office | 58 | 20 | $82.64 | $4,793 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 16 | 16 | $17.83 | $285 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 14 | 14 | $17.85 | $250 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 13 | 13 | $122.11 | $1,587 |
By year: 2022 $45K for 800 services; 2023 $28K for 535 services; 2024 $26K for 433 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kwesi Grant-Acquah prescribed most often to Medicare patients was Oxycodone Hcl, with 677 prescriptions and refills. In total Kwesi Grant-Acquah wrote 10,006 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 677 | 677 | 69 | $9,074 |
| Promethazine Hcl Generic | 650 | 650 | 41 | $10K |
| Gabapentin Generic | 343 | 406 | 51 | $5,219 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 338 | 372 | 64 | $6,667 |
| Amlodipine Besylate Generic | 300 | 605 | 65 | $1,683 |
| Atorvastatin Calcium Generic | 239 | 463 | 56 | $1,713 |
| Pantoprazole Sodium Generic | 223 | 368 | 51 | $1,863 |
| Cyclobenzaprine Hcl Generic | 183 | 229 | 29 | $3,057 |
| Pregabalin Generic | 181 | 183 | 23 | $2,769 |
| Ozempic Semaglutide | 177 | 202 | 23 | $190K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 173 | 173 | 19 | $5,026 |
| Linzess Linaclotide | 164 | 227 | 29 | $125K |
| Fluticasone Propionate Generic | 156 | 262 | 43 | $2,007 |
| Potassium Chloride Generic | 152 | 222 | 36 | $1,121 |
| Zolpidem Tartrate Generic | 141 | 141 | 18 | $1,049 |
Brand drugs: 1,731 claims; generic drugs: 8,235 claims; opioid claims: 1,206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kwesi Grant-Acquah $2,289 ($2,289 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $459.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $459 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $404 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $387 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $178 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $119 |
| Lundbeck LLC | 3 | $91.38 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $90.64 |
| Aimmune Therapeutics, Inc. | 4 | $75.64 |
| Lilly USA, LLC LLY | 3 | $72.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.